ABL Diagnostics Stock Went Down By Over 33% In The Last 21 Sessions

(VIANEWS) – Shares of ABL Diagnostics (CAC 40: ABLD.PA) fell by a staggering 33.33% in 21 sessions from €8.7 to €5.80 at 05:37 EST on Friday, after five successive sessions in a row of losses. CAC 40 is jumping 0.64% to €7,446.89, following the last session’s upward trend.

About ABL Diagnostics

ABL Diagnostics Société anonyme does not have significant operations. The company was formerly known as Etablissements Fauvet Girel and changed its name to ABL Diagnostics Société anonyme in April 2022. The company is headquartered in Paris, France. ABL Diagnostics Société anonyme is a subsidiary of Advanced Biological Laboratories (ABL) S.A.

Earnings Per Share

As for profitability, ABL Diagnostics has a trailing twelve months EPS of €-0.08.

More news about ABL Diagnostics (ABLD.PA).

Leave a Reply

Your email address will not be published. Required fields are marked *